lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate

C36H23LiN3O+ — CID 140600462

IUPAClithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate
SMILES[Li+].[O-]c1ccc(-c2c3ccccc3cc3ccc(-c4nc5ccccc5n4-c4ccccc4)cc23)c2ccc[nH+]c12
InChIInChI=1S/C36H23N3O.Li/c40-33-19-18-28(29-13-8-20-37-35(29)33)34-27-12-5-4-9-23(27)21-24-16-17-25(22-30(24)34)36-38-31-14-6-7-15-32(31)39(36)26-10-2-1-3-11-26;/h1-22,40H;/q;+1
InChIKeyDZPNLOWQFXEHNQ-UHFFFAOYSA-N
MW520.54 g/mol
LogP4.71
Rot. Bonds3

About lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate

lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate (PubChem CID 140600462) has the molecular formula C36H23LiN3O+ and a molecular weight of 520.54 g/mol. Its IUPAC name is lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate.

Molecular Properties

Compound Namelithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate
PubChem CID140600462
Molecular FormulaC36H23LiN3O+
Molecular Weight520.54 g/mol
Exact Mass520.20
IUPAC Namelithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate
SMILES[Li+].[O-]c1ccc(-c2c3ccccc3cc3ccc(-c4nc5ccccc5n4-c4ccccc4)cc23)c2ccc[nH+]c12
InChIInChI=1S/C36H23N3O.Li/c40-33-19-18-28(29-13-8-20-37-35(29)33)34-27-12-5-4-9-23(27)21-24-16-17-25(22-30(24)34)36-38-31-14-6-7-15-32(31)39(36)26-10-2-1-3-11-26;/h1-22,40H;/q;+1
InChIKeyDZPNLOWQFXEHNQ-UHFFFAOYSA-N
XLogP4.71
TPSA55.02 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms41
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500520.54
LogP ≤ 54.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-(1H-benzimidazol-2-ylmethyl)-3-[(4-fluorophenyl)methyl]-7-methylpyrrolo[3,4-g]quinoline-8,9-diol
CID 91170969
3-[7-[3-(8-fluoroquinolin-2-yl)indol-1-yl]-1H-benzimidazol-2-yl]naphthalen-2-ol
CID 144941124
5-((2-(4-Hydroxyphenyl)-4,5-diphenyl-1h-imidazol-1-yl)methyl)quinolin-8-ol
CID 156613324
10-acridin-9-ylanthracen-9-ol;1H-imidazole
CID 168327448
Beryllium bis(2-(3-methylbenzo[e]benzimidazol-1-ium-2-yl)naphthalen-1-olate)
CID 57621813
Beryllium;benzo[h]quinolin-1-ium-10-olate;2-(1-phenylbenzimidazol-3-ium-2-yl)phenolate
CID 57735208
Beryllium;benzo[h]quinolin-1-ium-10-olate;2-(1-phenylbenzimidazol-3-ium-2-yl)phenol;hydroxide
CID 57903534
11-[2-(1H-benzimidazol-2-yl)phenoxy]-10,12-dioxa-3-aza-11-indatetracyclo[11.8.0.04,9.016,21]henicosa-1(13),2,4,6,8,14,16,18,20-nonaene
CID 58886970
Beryllium;5,6-dihydrobenzo[h]quinolin-1-ium-10-olate;2-(1-phenylbenzimidazol-3-ium-2-yl)phenolate
CID 59236266
5-[(5-phenyl-1H-imidazol-2-yl)methyl]quinolin-8-ol
CID 67062745
8-(tert-Butyldimethylsilanyloxy)-5-[4-(1-phenyl-1H-benzimidazol-2-yl)phenyl]quinoline
CID 67362201
2-[[1-[2-[(8-hydroxyquinolin-2-yl)methylamino]ethyl]benzimidazol-2-yl]methyl]-3H-benzimidazole-5-carboximidamide
CID 70138730

Frequently Asked Questions

What is the IUPAC name of lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate?
The IUPAC name of lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate (CID 140600462) is lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate.
What is the SMILES notation for lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate?
The canonical SMILES for lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate is [Li+].[O-]c1ccc(-c2c3ccccc3cc3ccc(-c4nc5ccccc5n4-c4ccccc4)cc23)c2ccc[nH+]c12.
What is the InChIKey of lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate?
The InChIKey is DZPNLOWQFXEHNQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H23N3O.Li/c40-33-19-18-28(29-13-8-20-37-35(29)33)34-27-12-5-4-9-23(27)21-24-16-17-25(22-30(24)34)36-38-31-14-6-7-15-32(31)39(36)26-10-2-1-3-11-26;/h1-22,40H;/q;+1.
What are the key properties of lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate?
lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate has a molecular weight of 520.54 g/mol, XLogP of 4.71, 3 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for lithium 5-[2-(1-phenylbenzimidazol-2-yl)anthracen-9-yl]quinolin-1-ium-8-olate is sourced from PubChem (CID 140600462), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).